Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04701060 |
|---|---|
| Brief Title: | Camrelizumab Combined With Apatinib for Perioperative Treatment of Resectable Primary Hepatocellular Carcinoma |
| First Submitted : | January 4, 2021 |
| First Submitted that Met QC Criteria : | January 7, 2021 |
| First Posted : | January 8, 2021 |
| Last Update Submitted that Met QC Criteria : | November 3, 2021 |
| Last Update Posted : | November 5, 2021 |